ZANKEL TODD C,UNITT JOHN,PHILLIPS TIMOTHY,GOURDET BENOIT,DUFFY LOMA
申请号：
IN201847003223
公开号：
IN201847003223A
申请日:
2018.01.29
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
The present invention is directed to ADO-resistant cysteamine analogs for use in methods of treating diseases for which cysteamine is indicated, in particular cystinosis, fatty liver disease, fibrosis, thrombotic diseases, MECP-2 related disorders, inherited mitochondrial diseases, neurological diseases or disorders, inflammation and cancer.
